908 DEVICES INC. (MASS) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Win.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Win.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Lose.
26/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 7 wins, 5 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q22/3 |
WinMASS / S&P 42.16% / 15.20% |
LoseMASS / S&P 13.35% / 15.00% |
WinMASS / S&P 74.07% / 50.40% |
| 2026-Q12/3 |
WinMASS / S&P 16.57% / -4.33% |
LoseMASS / S&P 10.94% / 11.30% |
WinMASS / S&P 83.33% / 27.70% |
| 2025-Q41/3 |
LoseMASS / S&P -40.07% / 2.65% |
WinMASS / S&P 17.70% / 9.00% |
LoseMASS / S&P -126.67% / 13.40% |
| 2025-Q32/3 |
WinMASS / S&P 22.86% / 8.12% |
WinMASS / S&P 11.32% / 4.61% |
LoseMASS / S&P -93.79% / 13.45% |
| 2025-Q22/3 |
WinMASS / S&P 59.15% / 10.94% |
WinMASS / S&P 12.92% / 4.83% |
LoseMASS / S&P -53.04% / 10.63% |
| 2025-Q12/3 |
WinMASS / S&P 103.64% / -4.27% |
WinMASS / S&P 8.17% / 4.98% |
LoseMASS / S&P -49.53% / 10.57% |
| 2024-Q41/3 |
LoseMASS / S&P -36.60% / 2.41% |
LoseMASS / S&P -4.94% / 5.25% |
WinMASS / S&P 85.84% / 6.15% |
| 2024-Q31/3 |
LoseMASS / S&P -32.62% / 5.89% |
LoseMASS / S&P 0.49% / 5.89% |
WinMASS / S&P 46.28% / 6.11% |
| 2024-Q20/3 |
LoseMASS / S&P -31.79% / 4.28% |
LoseMASS / S&P -3.04% / 5.38% |
LoseMASS / S&P -3.36% / 5.12% |
| 2024-Q10/3 |
LoseMASS / S&P -32.71% / 10.56% |
LoseMASS / S&P 0.27% / 5.71% |
LoseMASS / S&P -7.76% / 5.59% |
| 2023-Q42/3 |
WinMASS / S&P 68.47% / 11.69% |
WinMASS / S&P 7.21% / 6.81% |
LoseMASS / S&P 5.61% / 7.78% |
| 2023-Q32/3 |
WinMASS / S&P -2.92% / -3.27% |
LoseMASS / S&P -6.91% / 7.52% |
WinMASS / S&P 39.08% / -5.03% |
| 2023-Q21/3 |
LoseMASS / S&P -20.23% / 8.74% |
LoseMASS / S&P 2.56% / 9.50% |
WinMASS / S&P 38.37% / -8.57% |
| 2023-Q12/3 |
WinMASS / S&P 12.86% / 7.50% |
LoseMASS / S&P 6.81% / 10.77% |
WinMASS / S&P 33.33% / -15.69% |
| 2022-Q41/3 |
LoseMASS / S&P -53.68% / 7.56% |
LoseMASS / S&P 11.01% / 11.88% |
WinMASS / S&P 35.44% / -17.99% |
| 2022-Q31/3 |
LoseMASS / S&P -20.11% / -4.88% |
WinMASS / S&P 59.12% / 13.47% |
LoseMASS / S&P -65.20% / -1.41% |
| 2022-Q22/3 |
WinMASS / S&P 8.31% / -16.10% |
WinMASS / S&P 86.82% / 13.71% |
LoseMASS / S&P -67.55% / 11.04% |
| 2022-Q11/3 |
LoseMASS / S&P -26.52% / -4.60% |
WinMASS / S&P 58.14% / 15.97% |
LoseMASS / S&P -61.84% / 42.23% |
| 2021-Q41/3 |
LoseMASS / S&P -20.45% / 11.03% |
WinMASS / S&P 56.93% / 15.00% |
LoseMASS / S&P -70.30% / 96.40% |
| 2021-Q30/3 |
LoseMASS / S&P -16.08% / 0.58% |
LoseMASS / S&P MASS unavailable / 10.77% |
LoseMASS / S&P MASS unavailable / 69.42% |
| 2021-Q20/3 |
LoseMASS / S&P -20.10% / 8.55% |
LoseMASS / S&P MASS unavailable / 6.58% |
LoseMASS / S&P MASS unavailable / 51.81% |
| 2021-Q10/3 |
LoseMASS / S&P -14.84% / 6.17% |
LoseMASS / S&P MASS unavailable / -1.06% |
LoseMASS / S&P MASS unavailable / 7.39% |
| 2020-Q40/3 |
LoseMASS / S&P MASS unavailable / 12.15% |
LoseMASS / S&P MASS unavailable / -3.72% |
LoseMASS / S&P MASS unavailable / -33.42% |
| 2020-Q30/3 |
LoseMASS / S&P MASS unavailable / 8.93% |
LoseMASS / S&P MASS unavailable / -2.04% |
LoseMASS / S&P MASS unavailable / -27.10% |
| 2020-Q20/3 |
LoseMASS / S&P MASS unavailable / 20.54% |
LoseMASS / S&P MASS unavailable / -0.46% |
LoseMASS / S&P MASS unavailable / -27.11% |
| 2020-Q10/3 |
LoseMASS / S&P MASS unavailable / -19.60% |
LoseMASS / S&P MASS unavailable / 3.47% |
LoseMASS / S&P MASS unavailable / -14.75% |
| 2019-Q40/3 |
LoseMASS / S&P MASS unavailable / 9.07% |
LoseMASS / S&P MASS unavailable / 5.36% |
LoseMASS / S&P MASS unavailable / 2.99% |
| 2019-Q30/3 |
LoseMASS / S&P MASS unavailable / 1.70% |
LoseMASS / S&P MASS unavailable / 5.02% |
LoseMASS / S&P MASS unavailable / 0.21% |
| 2019-Q20/3 |
LoseMASS / S&P MASS unavailable / 4.30% |
LoseMASS / S&P MASS unavailable / 6.64% |
LoseMASS / S&P MASS unavailable / 8.65% |
| 2019-Q10/3 |
LoseMASS / S&P MASS unavailable / 13.65% |
LoseMASS / S&P MASS unavailable / 8.12% |
LoseMASS / S&P MASS unavailable / 14.29% |
| 2018-Q40/3 |
LoseMASS / S&P MASS unavailable / -13.52% |
LoseMASS / S&P MASS unavailable / 9.05% |
LoseMASS / S&P MASS unavailable / 18.23% |
| 2018-Q30/3 |
LoseMASS / S&P MASS unavailable / 7.71% |
LoseMASS / S&P MASS unavailable / 10.21% |
LoseMASS / S&P MASS unavailable / 19.06% |
| 2018-Q20/3 |
LoseMASS / S&P MASS unavailable / 3.43% |
LoseMASS / S&P MASS unavailable / 9.03% |
LoseMASS / S&P MASS unavailable / 14.46% |
| 2018-Q10/3 |
LoseMASS / S&P MASS unavailable / -0.76% |
LoseMASS / S&P MASS unavailable / 7.68% |
LoseMASS / S&P MASS unavailable / 12.46% |
| 2017-Q40/3 |
LoseMASS / S&P MASS unavailable / 6.64% |
LoseMASS / S&P MASS unavailable / 7.03% |
LoseMASS / S&P MASS unavailable / 13.82% |
| 2017-Q30/3 |
LoseMASS / S&P MASS unavailable / 4.48% |
LoseMASS / S&P MASS unavailable / 5.68% |
LoseMASS / S&P MASS unavailable / 17.57% |
| 2017-Q20/3 |
LoseMASS / S&P MASS unavailable / 3.09% |
LoseMASS / S&P MASS unavailable / 4.83% |
LoseMASS / S&P MASS unavailable / 17.74% |
| 2017-Q10/3 |
LoseMASS / S&P MASS unavailable / 6.07% |
LoseMASS / S&P MASS unavailable / 3.67% |
LoseMASS / S&P MASS unavailable / 13.32% |
| 2016-Q40/3 |
LoseMASS / S&P MASS unavailable / 3.82% |
LoseMASS / S&P MASS unavailable / 2.09% |
LoseMASS / S&P MASS unavailable / 7.05% |
| 2016-Q30/3 |
LoseMASS / S&P MASS unavailable / 3.85% |
LoseMASS / S&P MASS unavailable / 0.20% |
LoseMASS / S&P MASS unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | MASS total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 77.60% | 20.78% |
| Annualized return | 77.60% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | MASS total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -69.25% | 83.14% |
| Annualized return | -21.01% | 12.86% |
10Y · 2020-12-18 to 2026-08-27
| Metric | MASS total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -77.35% | 319.30% |
| Annualized return | -13.80% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |